Clusterin Immunoexpression and its Clinical Significance in Patients with Non-Small Cell Lung Cancer
β Scribed by Hecheng Li; Shilei Liu; XiaoLi Zhu; Shuo Yang; Jiaqing Xiang; Haiquan Chen
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 384 KB
- Volume
- 188
- Category
- Article
- ISSN
- 0341-2040
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background. Little is known about the relationship between DNA histogram data and the clinical course of small cell lung cancer (SCLC). Methods. The ability of tumor nuclear DNA histograms as measured by cytofluorometry to predict chemotherapeutic responsiveness and propensity for metastases w
## Abstract Methylationβassociated inactivation of __RASSF1__, a putative tumor suppressor identified at 3p21.3, is reported in several cancers. We examined __RASSF1__ in nonβsmall lung cancer (NSCLC) to search for clinical implications. RTβPCR analysis showed no expression of __RASSF1A__ in 12 of